Treatment of cancers of lymphocytic cells with product R

Details Treatment of cancers of lymphocytic cells with product R Treatment of cancers of lymphocytic cells with product R

2007-02-08

2008-12-16

Tsang, Cecilia J (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07465711

ABSTRACT:
A method of treating a patient suffering from cancers of lymph cells such as acute lymphocytic leukemia, chronic lymphocytic leukemia, Hodgkin's disease and non-Hodgkin's lymphoma comprises parenterally administering to said patient an effective acute lymphocytic leukemia treatment amount of Product R in a pharmaceutically acceptable formulation.

REFERENCES:
patent: 5807839 (1998-09-01), Hirschman
patent: 5807840 (1998-09-01), Hirschman
patent: 5849196 (1998-12-01), Kochel
patent: 5902786 (1999-05-01), Bregman
patent: 6268349 (2001-07-01), Hirschman
patent: 6303153 (2001-10-01), Friedland et al.
patent: 6312602 (2001-11-01), Kochel
patent: 6355226 (2002-03-01), Hirschman
patent: 6440658 (2002-08-01), Huang et al.
patent: 6528098 (2003-03-01), Friedland et al.
patent: 6670118 (2003-12-01), Hirschman
patent: 6696422 (2004-02-01), Hirschman
patent: 6921542 (2005-07-01), Friedland et al.
patent: 7067139 (2006-06-01), Hirschman
patent: 7074767 (2006-07-01), Friedland et al.
patent: 2001/0006682 (2001-07-01), Hirschman
patent: 2001/0049351 (2001-12-01), Hirschman
patent: 2002/0055483 (2002-05-01), Watanabe et al.
patent: 2002/0081627 (2002-06-01), Hirschman
patent: 2002/0107184 (2002-08-01), Hirschman
patent: 2003/0206962 (2003-11-01), Hirschman
patent: 2004/0033244 (2004-02-01), Hirschman
Notice of Allowance corresponding to U.S. Appl. No. 10/456,668 dated Apr. 30, 2007.
Notice of Allowance corresponding to U.S. Appl. No. 10/456,668 dated Jun. 6, 2008.
Official Communication corresponding to U.S. Appl. No. 10/466,895 dated Aug. 9, 2006, Sep. 11, 2008.
Official Communication corresponding to U.S. Appl. No. 10/456,668 dated Jun. 28, 2006.
Official Communication corresponding to U.S. Appl. No. 10/456,668 dated Oct. 10, 2007.
Official Communication corresponding to U.S. Appl. No. 10/559,690 dated Jun. 26, 2008.

Affiliated with

Also associated with

Rating

Treatment of cancers of lymphocytic cells with product R does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cancers of lymphocytic cells with product R, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancers of lymphocytic cells with product R will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4040658